Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 3
2016 pubmed

Identification of Human Cathelicidin Peptide LL-37 as a Ligand for Macrophage Integrin &#x3b1;<sub>M</sub>&#x3b2;<sub>2</sub> (Mac-1, CD11b/CD18) that Promotes Phagocytosis by Opsonizing Bacteria.

Lishko. Valeryi K VK; Moreno. Benjamin B; Podolnikova. Nataly P NP; Ugarova. Tatiana P TP

Key Findings

  • LL‑37 directly binds the Mac‑1 (αMβ2) integrin on monocytes, macrophages, and neutrophils
  • Binding of LL‑37 enhances cell adhesion and triggers migration of immune cells
  • Coating bacteria with LL‑37 dramatically increases their phagocytosis by macrophages, an effect blocked by anti‑Mac‑1 antibodies and heparin

Practical Outcomes

  • Boosting your body’s LL‑37 levels—through vitamin D optimization, certain diets, or safe peptide‑based approaches—might sharpen innate immune clearance of microbes. However, there’s no proven oral or injectable LL‑37 supplement yet, so the finding is more a mechanistic insight than a ready‑to‑use protocol.

Summary

The study shows that the natural antimicrobial peptide LL‑37 can stick to a receptor called Mac‑1 on immune cells, helping those cells grab and eat bacteria more efficiently. When bacteria are coated with LL‑37, macrophages eat them faster, but this only works if the Mac‑1 receptor and certain surface sugars are present.

Abstract

LL-37, a cationic antimicrobial peptide, has numerous immune-modulating effects. However, the identity of a receptor(s) mediating the responses in immune cells remains uncertain. We have recently demonstrated that LL-37 interacts with the &#x3b1;<sub>M</sub>I-domain of integrin &#x3b1;<sub>M</sub>&#x3b2;<sub>2</sub> (Mac-1), a major receptor on the surface of myeloid cells, and induces a migratory response in Mac-1-expressing monocyte/macrophages as well as activation of Mac-1 on neutrophils. Here, we show that LL-37 and its C-terminal derivative supported strong adhesion of various Mac-1-expressing cells, including HEK293 cells stably transfected with Mac-1, human U937 monocytic cells and murine IC-21 macrophages. The cell adhesion to LL-37 was partially inhibited by specific Mac-1 antagonists, including mAb against the &#x3b1;<sub>M</sub> integrin subunit and neutrophil inhibitory factor, and completely blocked when anti-Mac-1 antibodies were combined with heparin, suggesting that cell surface heparan sulfate proteoglycans act cooperatively with integrin Mac-1. Coating both Gram-negative and Gram-positive bacteria with LL-37 significantly potentiated their phagocytosis by macrophages, and this process was blocked by a combination of anti-Mac-1 mAb and heparin. Furthermore, phagocytosis by wild-type murine peritoneal macrophages of LL-37-coated latex beads, a model of foreign surfaces, was several fold higher than that of untreated beads. By contrast, LL-37 failed to augment phagocytosis of beads by Mac-1-deficient macrophages. These results identify LL-37 as a novel ligand for integrin Mac-1 and demonstrate that the interaction between Mac-1 on macrophages and bacteria-bound LL-37 promotes phagocytosis.

Study Information

Provider

pubmed

Year

2016

Date

2016-07-07T00:00:00.000Z

DOI

10.2147/rrbc.s107070